Marijne Vandebergh

Antwerpen, VLG 2610, Belgium

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications

Interplay between genetic and environmental risk factors in multiple sclerosis: what have we learned?

Interplay between genetic and environmental risk factors in multiple sclerosis: what have we learned?

Journal: Brain : a journal of neurology
Published: November 04, 2025

Individualized Atrophy-Based Prediction of Dementia Progression in Familial Frontotemporal Lobar Degeneration With Bayesian Linear Mixed-Effects Modeling.

Individualized Atrophy-Based Prediction of Dementia Progression in Familial Frontotemporal Lobar Degeneration With Bayesian Linear Mixed-Effects Modeling.

Journal: Annals of neurology
Published: July 23, 2025

Author Correction: Large-scale network analysis of the cerebrospinal fluid proteome identifies molecular signatures of frontotemporal lobar degeneration.

Author Correction: Large-scale network analysis of the cerebrospinal fluid proteome identifies molecular signatures of frontotemporal lobar degeneration.

Journal: Nature aging
Published: July 07, 2025

Association of Initial Side of Brain Atrophy With Clinical Features and Disease Progression in Patients With GRN Frontotemporal Dementia.

Association of Initial Side of Brain Atrophy With Clinical Features and Disease Progression in Patients With GRN Frontotemporal Dementia.

Journal: Neurology
Published: November 11, 2024

Gene-Specific Effects on Brain Volume and Cognition of TMEM106B in Frontotemporal Lobar Degeneration.

Gene-Specific Effects on Brain Volume and Cognition of TMEM106B in Frontotemporal Lobar Degeneration.

Journal: Neurology
Published: September 25, 2024

Gene specific effects on brain volume and cognition of TMEM106B in frontotemporal lobar degeneration.

Gene specific effects on brain volume and cognition of TMEM106B in frontotemporal lobar degeneration.

Journal: medRxiv : the preprint server for health sciences
Published: April 18, 2024

Large-scale network analysis of the cerebrospinal fluid proteome identifies molecular signatures of frontotemporal lobar degeneration.

Large-scale network analysis of the cerebrospinal fluid proteome identifies molecular signatures of frontotemporal lobar degeneration.

Journal: Research square
Published: April 08, 2024

Large-scale network analysis of the cerebrospinal fluid proteome identifies molecular signatures of frontotemporal lobar degeneration.

Large-scale network analysis of the cerebrospinal fluid proteome identifies molecular signatures of frontotemporal lobar degeneration.

Journal: Nature aging
Published: March 22, 2024

Environmental risk factors in multiple sclerosis: bridging Mendelian randomization and observational studies.

Environmental risk factors in multiple sclerosis: bridging Mendelian randomization and observational studies.

Journal: Journal of neurology
Published: February 26, 2022

Genetics of multiple sclerosis: lessons from polygenicity.

Genetics of multiple sclerosis: lessons from polygenicity.

Journal: The Lancet. Neurology
Published: January 12, 2022

Body Mass Index, Interleukin-6 Signaling and Multiple Sclerosis: A Mendelian Randomization Study.

Body Mass Index, Interleukin-6 Signaling and Multiple Sclerosis: A Mendelian Randomization Study.

Journal: Frontiers in immunology
Published: December 13, 2021

Effects of Vitamin D and Body Mass Index on Disease Risk and Relapse Hazard in Multiple Sclerosis: A Mendelian Randomization Study.

Effects of Vitamin D and Body Mass Index on Disease Risk and Relapse Hazard in Multiple Sclerosis: A Mendelian Randomization Study.

Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: October 01, 2021
Showing 1-12 of 19

Last Updated: 09/26/2026